BMRN

#862
BioMarin Pharmaceuticals Inc
55.44 USD
-0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
55.39
55.47
Rango anual
50.76
66.28
Cambio diario
-0.05%
Variación mensual
-2.17%
Variación en los últimos 6 meses
+4.43%
Cambio anual
-7.29%
Cierres anteriores
55.47
Abrir
55.40
Bid
Ask
Mínimo
55.39
High
55.47
Volumen
84
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Noticias